Pharma’s post-pandemic launch performance problem: what’s the prognosis?
pharmaphorum
JUNE 29, 2022
Lockdowns are no longer; but the more hybrid model of physician and patient engagement is here to stay; the challenge for launching companies is how to optimise engagement impact and patient opportunity within them. Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry. appeared first on.
59 
Let's personalize your content